Company Executives

$ARVN Management Team

Dr. John Houston

Chairman of the Board

President

Chief Executive Officer

Age 65

Compensation $12.75M USD

Sex Male

Mr. Andrew Saik

Chief Financial Officer

Treasurer

Age 55

Compensation $3.466M USD

Sex Male

Dr. Angela Cacace

Chief Scientific Officer

Age 57

Compensation $2.972M USD

Sex Female

Dr. Noah Berkowitz

Chief Medical Officer

Age 61

Compensation $5.982M USD

Sex Male

Name / Title	Age	Compensation	Sex
Dr. John Houston Chairman of the Board President Chief Executive Officer	65	$12.75M USD	Male
Mr. Andrew Saik Chief Financial Officer Treasurer	55	$3.466M USD	Male
Dr. Angela Cacace Chief Scientific Officer	57	$2.972M USD	Female
Dr. Noah Berkowitz Chief Medical Officer	61	$5.982M USD	Male

Board of Directors

From the proxy statement filed Apr 29, 2026

Directors

serving now

Independent

7 of 9

stated in the proxy

Average tenure

5.8 years

from year joined

CEO also chairs the board

Briggs Morrison

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Leslie V. Norwalk	60	2019 7 years	Independent	Audit Committee Compensation Committee · Chair	CVS Health, Neurocrine Biosciences, Inc., Globus, Inc.	Not stated
Randy Teel CEO	47	2026 0 years	Not independent	None stated	None stated	Paid as CEO
Linda Bain	55	2020 6 years	Independent	Audit Committee · Chair	Autolus Therapeutics plc	$314,965
John Houston	66	2017 9 years	Not independent	None stated	NextCure, Inc.	Not stated
Laurie Smaldone Alsup	72	2019 7 years	Independent	Compensation Committee Science and Technology Committee	Theravance Biopharma, Inc.	$309,965
Everett Cunningham	59	2022 4 years	Independent	Audit Committee Compensation Committee	Quanterix	$312,465
Edward Kennedy, Jr.	64	2018 8 years	Independent	Nominating and Corporate Governance Committee · Chair	InnovAge Holding Corp.	$304,965
Briggs Morrison Board chair	67	2018 8 years	Independent	Nominating and Corporate Governance Committee Science and Technology Committee	CRISPR Therapeutics AG, Werewolf Therapeutics Inc.	$337,465
Sunil Agarwal Leaving at the meeting	Not stated	2023 3 years	Independent	Science and Technology Committee · Chair	None stated	$314,965

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ARVN Management Team

Dr. John Houston

Mr. Andrew Saik

Dr. Angela Cacace

Dr. Noah Berkowitz

Board of Directors

Related-party transactions

No related-party transactions disclosed